Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
14933 | 741 | 41.0 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
159 | 3 | MENOPAUSE//ISOFLAVONES//TAMOXIFEN | 61134 |
1407 | 2 | 2 METHOXYESTRADIOL//STEROID SULFATASE//17 BETA HYDROXYSTEROID DEHYDROGENASE | 8029 |
14933 | 1 | CYP1B1//CYP2S1//CYP2W1 | 741 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CYP1B1 | authKW | 1094280 | 13% | 28% | 96 |
2 | CYP2S1 | authKW | 412069 | 1% | 100% | 10 |
3 | CYP2W1 | authKW | 293025 | 1% | 89% | 8 |
4 | CYP19A1 | authKW | 289339 | 3% | 28% | 25 |
5 | CYP17 | authKW | 239317 | 5% | 17% | 34 |
6 | CYP19 | authKW | 233449 | 5% | 17% | 34 |
7 | CYTOCHROME P4501B1 | authKW | 199015 | 2% | 30% | 16 |
8 | CYTOCHROME P450 CYP1B1 | authKW | 131861 | 1% | 80% | 4 |
9 | CYP19A1 POLYMORPHISMS | authKW | 123621 | 0% | 100% | 3 |
10 | ALA119SER | authKW | 82414 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 6048 | 47% | 0% | 347 |
2 | Toxicology | 344 | 7% | 0% | 53 |
3 | Pharmacology & Pharmacy | 293 | 14% | 0% | 103 |
4 | Public, Environmental & Occupational Health | 259 | 9% | 0% | 66 |
5 | Genetics & Heredity | 212 | 8% | 0% | 62 |
6 | Obstetrics & Gynecology | 184 | 6% | 0% | 41 |
7 | Endocrinology & Metabolism | 161 | 7% | 0% | 51 |
8 | Reproductive Biology | 63 | 2% | 0% | 16 |
9 | Biochemistry & Molecular Biology | 50 | 12% | 0% | 86 |
10 | Medical Laboratory Technology | 32 | 1% | 0% | 10 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AFFILIATED ZHEJIANG CANC HOSP | 54941 | 0% | 67% | 2 |
2 | ZHONGSHAN HOSP CANC | 54941 | 0% | 67% | 2 |
3 | ARBEITSGRP TOXIKOL EXOSITIONSFOR | 41207 | 0% | 100% | 1 |
4 | AXE ENDOCRINOL GENOM RECH | 41207 | 0% | 100% | 1 |
5 | BIOCHEM BIOL PL | 41207 | 0% | 100% | 1 |
6 | BIOMED SCI LIFE SCI LIB | 41207 | 0% | 100% | 1 |
7 | CANADA CHAIR HUMAN GENET | 41207 | 0% | 100% | 1 |
8 | CANC HUMAN CANC GENET GRP | 41207 | 0% | 100% | 1 |
9 | CANC PREVENT INTERVENT PROGRAM | 41207 | 0% | 100% | 1 |
10 | CANC UNITED KINGDOM GENET EPIDEMIOL GRP | 41207 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 13829 | 6% | 1% | 46 |
2 | BREAST CANCER RESEARCH AND TREATMENT | 6164 | 4% | 0% | 33 |
3 | PHARMACOGENETICS | 3514 | 1% | 1% | 9 |
4 | BREAST CANCER RESEARCH | 1881 | 1% | 0% | 10 |
5 | PHARMACOGENOMICS | 1475 | 1% | 0% | 8 |
6 | PHARMACOGENETICS AND GENOMICS | 1297 | 1% | 1% | 6 |
7 | CANCER LETTERS | 1202 | 3% | 0% | 19 |
8 | DRUG METABOLISM REVIEWS | 1026 | 1% | 1% | 5 |
9 | CARCINOGENESIS | 1000 | 2% | 0% | 17 |
10 | CANCER RESEARCH | 971 | 4% | 0% | 31 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYP1B1 | 1094280 | 13% | 28% | 96 | Search CYP1B1 | Search CYP1B1 |
2 | CYP2S1 | 412069 | 1% | 100% | 10 | Search CYP2S1 | Search CYP2S1 |
3 | CYP2W1 | 293025 | 1% | 89% | 8 | Search CYP2W1 | Search CYP2W1 |
4 | CYP19A1 | 289339 | 3% | 28% | 25 | Search CYP19A1 | Search CYP19A1 |
5 | CYP17 | 239317 | 5% | 17% | 34 | Search CYP17 | Search CYP17 |
6 | CYP19 | 233449 | 5% | 17% | 34 | Search CYP19 | Search CYP19 |
7 | CYTOCHROME P4501B1 | 199015 | 2% | 30% | 16 | Search CYTOCHROME+P4501B1 | Search CYTOCHROME+P4501B1 |
8 | CYTOCHROME P450 CYP1B1 | 131861 | 1% | 80% | 4 | Search CYTOCHROME+P450+CYP1B1 | Search CYTOCHROME+P450+CYP1B1 |
9 | CYP19A1 POLYMORPHISMS | 123621 | 0% | 100% | 3 | Search CYP19A1+POLYMORPHISMS | Search CYP19A1+POLYMORPHISMS |
10 | ALA119SER | 82414 | 0% | 100% | 2 | Search ALA119SER | Search ALA119SER |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ZHOU, Q , WANG, Y , CHEN, AH , TAO, YL , SONG, HM , LI, W , TAO, J , ZUO, MZ , (2015) ASSOCIATION BETWEEN THE COMT VAL158MET POLYMORPHISM AND RISK OF CANCER: EVIDENCE FROM 99 CASE-CONTROL STUDIES.ONCOTARGETS AND THERAPY. VOL. 8. ISSUE . P. 2791 -2803 | 68 | 69% | 1 |
2 | LIU, JY , YANG, Y , LIU, ZZ , XIE, JJ , DU, YP , WANG, W , (2015) ASSOCIATION BETWEEN THE CYP1B1 POLYMORPHISMS AND RISK OF CANCER: A META-ANALYSIS.MOLECULAR GENETICS AND GENOMICS. VOL. 290. ISSUE 2. P. 739 -765 | 74 | 56% | 5 |
3 | SAK, K , (2017) THE VAL158MET POLYMORPHISM IN COMT GENE AND CANCER RISK: ROLE OF ENDOGENOUS AND EXOGENOUS CATECHOLS.DRUG METABOLISM REVIEWS. VOL. 49. ISSUE 1. P. 56 -83 | 76 | 53% | 0 |
4 | YAO, L , FANG, F , WU, Q , YANG, Z , ZHONG, Y , YU, L , (2010) NO ASSOCIATION BETWEEN CYP17 T-34C POLYMORPHISM AND BREAST CANCER RISK: A META-ANALYSIS INVOLVING 58,814 SUBJECTS.BREAST CANCER RESEARCH AND TREATMENT. VOL. 122. ISSUE 1. P. 221 -227 | 41 | 79% | 7 |
5 | QIN, X , PENG, QL , QIN, AP , CHEN, ZP , LIN, LW , DENG, Y , XIE, L , XU, JJ , LI, HW , LI, TJ , ET AL (2012) ASSOCIATION OF COMT VAL158MET POLYMORPHISM AND BREAST CANCER RISK: AN UPDATED META-ANALYSIS.DIAGNOSTIC PATHOLOGY. VOL. 7. ISSUE . P. - | 44 | 67% | 11 |
6 | HE, XF , WEI, W , LI, SX , SU, J , ZHANG, Y , YE, XH , LIU, Y , WANG, W , (2012) ASSOCIATION BETWEEN THE COMT VAL158MET POLYMORPHISM AND BREAST CANCER RISK: A META-ANALYSIS OF 30,199 CASES AND 38,922 CONTROLS.MOLECULAR BIOLOGY REPORTS. VOL. 39. ISSUE 6. P. 6811-6823 | 40 | 68% | 9 |
7 | GAJJAR, K , MARTIN-HIRSCH, PL , MARTIN, FL , (2012) CYP1B1 AND HORMONE-INDUCED CANCER.CANCER LETTERS. VOL. 324. ISSUE 1. P. 13 -30 | 63 | 40% | 25 |
8 | LI, CP , LONG, BS , QIN, XJ , LI, WX , ZHOU, Y , (2015) CYTOCHROME P1B1 (CYP1B1) POLYMORPHISMS AND CANCER RISK: A META-ANALYSIS OF 52 STUDIES.TOXICOLOGY. VOL. 327. ISSUE . P. 77 -86 | 34 | 67% | 7 |
9 | MAO, C , WANG, XW , HE, BF , QIU, LX , LIAO, RY , LUO, RC , CHEN, Q , (2010) LACK OF ASSOCIATION BETWEEN CYP17 MSPA1 POLYMORPHISM AND BREAST CANCER RISK: A META-ANALYSIS OF 22,090 CASES AND 28,498 CONTROLS.BREAST CANCER RESEARCH AND TREATMENT. VOL. 122. ISSUE 1. P. 259 -265 | 34 | 77% | 5 |
10 | BLACKBURN, HL , ELLSWORTH, DL , SHRIVER, CD , ELLSWORTH, RE , (2015) ROLE OF CYTOCHROME P450 GENES IN BREAST CANCER ETIOLOGY AND TREATMENT: EFFECTS ON ESTROGEN BIOSYNTHESIS, METABOLISM, AND RESPONSE TO ENDOCRINE THERAPY.CANCER CAUSES & CONTROL. VOL. 26. ISSUE 3. P. 319 -332 | 48 | 42% | 6 |
Classes with closest relation at Level 1 |